257 related articles for article (PubMed ID: 34841660)
1. Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.
Wang QZ; Zhang EL; Xing XY; Su MY; Lang N
Orthop Surg; 2021 Dec; 13(8):2405-2416. PubMed ID: 34841660
[TBL] [Abstract][Full Text] [Related]
2. Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.
He Y; Guo J; Ding X; van Ooijen PMA; Zhang Y; Chen A; Oudkerk M; Xie X
Eur Radiol; 2019 Oct; 29(10):5441-5451. PubMed ID: 30859281
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.
He Y; Wang J; Zhang J; Du L; Lu Y; Xu J; Yuan F; Tan Y; Ding X
J Int Med Res; 2018 Feb; 46(2):710-722. PubMed ID: 29239274
[TBL] [Abstract][Full Text] [Related]
4. Recurrence in giant cell tumour of bone: imaging features and risk factors.
Wang CS; Lou JH; Liao JS; Ding XY; Du LJ; Lu Y; Yan L; Chen KM
Radiol Med; 2013 Apr; 118(3):456-64. PubMed ID: 22872452
[TBL] [Abstract][Full Text] [Related]
5. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.
He Y; Wang J; Zhang J; Yuan F; Ding X
Radiol Med; 2017 Jul; 122(7):546-555. PubMed ID: 28271359
[TBL] [Abstract][Full Text] [Related]
7. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Zhang WB; Lu Y
Radiol Med; 2014 Nov; 119(11):861-70. PubMed ID: 24604549
[TBL] [Abstract][Full Text] [Related]
8. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
Duan DK; Zhang GC; Sun BJ; Ma TX; Zhao M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5039-5052. PubMed ID: 37318478
[TBL] [Abstract][Full Text] [Related]
9. Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage.
Zhou L; Zhu H; Lin S; Jin H; Zhang Z; Dong Y; Yang Q; Zhang C; Yuan T
Int Orthop; 2022 Feb; 46(2):381-390. PubMed ID: 34783889
[TBL] [Abstract][Full Text] [Related]
10. Giant cell tumor of bone with secondary aneurysmal bone cyst does not have a higher risk of local recurrence.
Tsukamoto S; Aiba H; Righi A; Nitta Y; Traversari M; Mavrogenis AF; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2023 Aug; 128(2):350-358. PubMed ID: 37053028
[TBL] [Abstract][Full Text] [Related]
11. Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases.
Tang H; Moro A; Feng W; Lai Y; Xiao Z; Liu Y; Wang K
J Surg Oncol; 2019 Sep; 120(3):359-365. PubMed ID: 31219620
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of Giant Cell Tumor of the Spine after Resection: A Report of 10 Cases.
Lin P; Lin N; Teng W; Wang SD; Pan WB; Huang X; Yan XB; Liu M; Li HY; Li BH; Sun LL; Wang Z; Zhou XZ; Ye ZM
Orthop Surg; 2018 May; 10(2):107-114. PubMed ID: 29878714
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients.
Wang Q; Zhang Y; Zhang E; Xing X; Chen Y; Su MY; Lang N
J Bone Oncol; 2021 Apr; 27():100354. PubMed ID: 33850701
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of MRI and Pathological Features of Giant Cell Tumor of Bone Boundary.
Chen L; Shi XL; Zhou ZM; Qin LD; Liu XH; Jiang L; Zhang QJ; Ding XY
Orthop Surg; 2019 Aug; 11(4):628-634. PubMed ID: 31422584
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
Li X; Guo W; Yang Y; Wei R; DU ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
[TBL] [Abstract][Full Text] [Related]
16. Features of grade 3 giant cell tumors of the distal radius associated with successful intralesional treatment.
Kang L; Manoso MW; Boland PJ; Healey JH; Athanasian EA
J Hand Surg Am; 2010 Nov; 35(11):1850-7. PubMed ID: 20934816
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
18. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
